Timing of anticoagulation after recent ischaemic stroke in patients with atrial fibrillation

DJ Seiffge, DJ Werring, M Paciaroni, J Dawson… - The Lancet …, 2019 - thelancet.com
Summary Background About 13–26% of all acute ischaemic strokes are related to non-
valvular atrial fibrillation, the most common cardiac arrhythmia globally. Deciding when to …

Treatments in ischemic stroke: current and future

MG Mosconi, M Paciaroni - European neurology, 2022 - karger.com
Abstract Background and Aim: Despite progress made over the last 30 years, stroke is still a
leading cause of disability and mortality; likewise, its burden is expected to increase over the …

[HTML][HTML] Early versus later anticoagulation for stroke with atrial fibrillation

U Fischer, M Koga, D Strbian, M Branca… - … England Journal of …, 2023 - Mass Medical Soc
Background The effect of early as compared with later initiation of direct oral anticoagulants
(DOACs) in persons with atrial fibrillation who have had an acute ischemic stroke is unclear …

The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society comprehensive guidelines for the management of atrial fibrillation

JG Andrade, M Aguilar, C Atzema, A Bell… - Canadian Journal of …, 2020 - Elsevier
Abstract The Canadian Cardiovascular Society (CCS) atrial fibrillation (AF) guidelines
program was developed to aid clinicians in the management of these complex patients, as …

[HTML][HTML] Фибрилляция и трепетание предсердий. Клинические рекомендации 2020

МГ Аракелян, ЛА Бокерия, ЕЮ Васильева… - Российский …, 2021 - cyberleninka.ru
Члены Рабочей группы подтвердили отсутствие финансовой поддержки/конфликта
интересов. В случае сообщения о наличии конфликта интересов, член (ы) Рабочей …

[HTML][HTML] 2020 Clinical guidelines for Atrial fibrillation and atrial flutter

MG Arakelyan, LA Bockeria… - Russian Journal of …, 2021 - russjcardiol.elpub.ru
clinical guidelines, atrial fibrillation, ischemic stroke, anticoagulant therapy, vitamin K
antagonists, direct oral anticoagulants, triple antiplatelet therapy, rhythm control, electrical …

Early versus delayed non–vitamin k antagonist oral anticoagulant therapy after acute ischemic stroke in atrial fibrillation (TIMING): a registry-based randomized …

J Oldgren, S Åsberg, Z Hijazi, P Wester, M Bertilsson… - Circulation, 2022 - Am Heart Assoc
Background: There are no evidence-based recommendations on the optimal time point to
initiate non–vitamin K antagonist oral anticoagulants (NOACs) after acute ischemic stroke in …

Antithrombotic treatment for secondary prevention of stroke and other thromboembolic events in patients with stroke or transient ischemic attack and non-valvular atrial …

CJM Klijn, M Paciaroni, E Berge… - European Stroke …, 2019 - journals.sagepub.com
Patients with ischemic stroke or transient ischemic attack and non-valvular atrial fibrillation
have a high risk of recurrent stroke and other vascular events. The aim of this guideline is to …

Ehra expert consensus document on the management of arrhythmias in frailty syndrome, endorsed by the heart rhythm society (hrs), asia pacific heart rhythm society …

I Savelieva, S Fumagalli, RA Kenny, S Anker… - Europace, 2023 - academic.oup.com
There is an increasing proportion of the general population surviving to old age with
significant chronic disease, multi-morbidity, and disability. The prevalence of pre-frail state …

Sex disparities in enrollment in recent randomized clinical trials of acute stroke: a meta-analysis

B Strong, J Pudar, AG Thrift, VJ Howard… - JAMA …, 2021 - jamanetwork.com
Importance The underenrollment of women in randomized clinical trials represents a threat
to the validity of the evidence supporting clinical guidelines and potential disparities in …